PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for February 18, 2005 Subscribe to this News Feed    
 

Hyaluronic Acid Injections Increase Visibility with Supermodel Spokesperson

Details the recent appointment of a supermodel as the face of the Restylane Hyaluronic acid Injection. Provides updates about Hyaluronic acid facial injections.

Mt. Kisco, NY (PRWEB) February 18, 2005 --- Hyaluronic acid products are poised to continue their fast growth, particularly in the form of hyaluronic acid injections, according to E-Hyaluronicacid.com. The latest reason behind this growth is Medicis recent announcement that it has appointed supermodel, Frederique van der Wal to be the new face of Restylane. Frederique, one of modelings most recognizing stars, has appeared on nine Cosmopolitan and in several other publications including Victorias Secret, Harpers Bazaar and Vogue.

Frederiques image will appear on the companys website and on its information brochures. Van der Wal will additionally serve as the products spokeswoman for the firms public relation campaign. Frederiques visibility, along with her personal endorsement of the product, is sure to increase the growing popularity of Restylane. Restylane which is primarily composed of hyaluronic acid, is already the number one dermal filler on the US market, and many plastic surgeons predict that it will eventually surpass collagen and botox © as the most popular non-surgical cosmetic treatment.

In accepting her new position, Frederique stated, Restylane is a product in which I truly believe...Maintaining a youthful appearance is vital to my career, so I was excited to find a natural, non-invasive treatment that can safely erase some of the fine lines Ive recently started to notice." Jonah Shacknai, Chairman and Chief Executive Officer of Medicis responded with, "[Frederiques enthusiasm for the product coupled with her immense success in the modeling and entertainment industries and great personality make her a natural choice for us."

The hyaluronic acid product Restylane is the first and only dermal filler made of crystal-clear gel called NASHA (Non-Animal Stabilized Hyaluronic Acid). Restylane uses a dual mechanism of action to correct wrinkles and folds. Upon being injected beneath the skin's surface, the NASHA gel adds natural volume and lift to smooth wrinkles and folds. The NASHA gel integrates into dermal tissue, then attracts and binds to water molecules to help maintain volume. Restylane is gradually degraded by the body's own mechanism and disappears without any residue. In addition, Restylane is the only FDA approved filler with clinical data supporting its efficacy for as long as six months.

Restylane does not require any allergy or skin test prior to injection. In addition, the reported hyaluronic acid injection side effects have been limited to temporary redness and swelling at the injection site. As such, Restylane appears to be one of safest and most effective options on the anti-aging market.

About Us
E-Hyaluronicacid.com is dedicated to promoting an understanding of Hyaluronic acid, a major ingredient in many medical and anti-aging therapies and to highlighting places where you can safely purchase Hyaluronic acid products. For more information go to http://www.E-Hyaluronicacid.com

Contact
Contact@E-Hyaluronicacid.com
http://www.E-Hyaluronicacid.com

###

Other Releases by this Member
OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Jana Willinger
HA Info">HA Info
914 -514-8036
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.